Covered recipient · General Payments record
ERIKA GUIDER
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2021–2024
$766.54
- Reported across 46 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $452.69 | 29 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $151.08 | 14 |
| Amgen Inc. | $143.09 | 7 |
| E.R. Squibb & Sons, L.L.C. | $46.54 | 2 |
| Arcutis Biotherapeutics, Inc. | $27.92 | 2 |
| GENZYME CORPORATION | $26.69 | 1 |
| UCB, Inc. | $24.28 | 1 |
| Janssen Biotech, Inc. | $18.50 | 1 |
| Lilly USA, LLC | $14.59 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (29)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $7.76 | 01/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107262659 | CMS |
| ABBVIE INC. | $15.82 | 02/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107262661 | CMS |
| ABBVIE INC. | $2.26 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107262663 | CMS |
| ABBVIE INC. | $6.22 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107262665 | CMS |
| ABBVIE INC. | $1.98 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107262667 | CMS |
| ABBVIE INC. | $3.19 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107262669 | CMS |
| ABBVIE INC. | $2.86 | 05/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107262671 | CMS |
| ABBVIE INC. | $2.40 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107262673 | CMS |
| ABBVIE INC. | $9.28 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107262675 | CMS |
| ABBVIE INC. | $19.64 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107262677 | CMS |
| ABBVIE INC. | $19.28 | 09/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107262679 | CMS |
| ABBVIE INC. | $13.80 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107262681 | CMS |
| ABBVIE INC. | $24.99 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107262683 | CMS |
| ABBVIE INC. | $21.60 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107262685 | CMS |
| Amgen Inc. | $13.43 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117569039 | CMS |
| Amgen Inc. | $24.04 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117569041 | CMS |
| Amgen Inc. | $25.60 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117569043 | CMS |
| Amgen Inc. | $20.01 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117569045 | CMS |
| Amgen Inc. | $26.58 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117569047 | CMS |
| Amgen Inc. | $16.73 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117569049 | CMS |
| Amgen Inc. | $16.70 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117569051 | CMS |
| Arcutis Biotherapeutics, Inc. | $13.72 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1121094123 | CMS |
| Arcutis Biotherapeutics, Inc. | $14.20 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1121094125 | CMS |
| E.R. Squibb & Sons, L.L.C. | $25.23 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101513850 | CMS |
| E.R. Squibb & Sons, L.L.C. | $21.31 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101513936 | CMS |
| GENZYME CORPORATION | $26.69 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139857042 | CMS |
| Janssen Biotech, Inc. | $18.50 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078366909 | CMS |
| Lilly USA, LLC | $14.59 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135658193 | CMS |
| UCB, Inc. | $24.28 | 10/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143190009 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.